Filing Details
- Accession Number:
- 0001127602-17-030354
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-10-26 18:51:28
- Reporting Period:
- 2017-10-24
- Accepted Time:
- 2017-10-26 18:51:28
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1110803 | Illumina Inc | ILMN | Laboratory Analytical Instruments (3826) | 330804655 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1189130 | T Jay Flatley | 5200 Illumina Way San Diego CA 92122 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-10-24 | 20,000 | $70.82 | 539,176 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-10-24 | 1,300 | $208.53 | 537,876 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-10-24 | 5,066 | $210.05 | 532,810 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-10-24 | 13,325 | $210.74 | 519,485 | No | 4 | S | Direct | |
Common Stock | Disposition | 2017-10-24 | 309 | $211.42 | 519,176 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Non-qualified Stock Option (Right to Buy) | Disposition | 2017-10-24 | 20,000 | $0.00 | 20,000 | $70.82 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
35,000 | 2011-03-01 | 2021-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 140 | Indirect | By Daughters |
Footnotes
- The sale was made pursuant to a 10b5-1 plan.
- Weighted average sale price representing 1,300 shares sold ranging from $208.09 to $208.85 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 5,066 shares sold ranging from $209.38 to $210.36 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 13,325 shares sold ranging from $210.38 to $211.37 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
- Weighted average sale price representing 309 shares sold ranging from $211.40 to $211.43 per share. Number of shares sold at each separate price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.